**About the Editors**

## **Viˇsnja Stepani´c**

Visnja Stepani ˇ c, Ph.D. received her doctorate from the Faculty of Science, University of Zagreb, ´ Croatia. She worked in the pharmaceutical industry at PLIVA and GSK and now works in the Machine Learning and Knowledge Representation Laboratory at the Rudjer Boskovi ˇ c Institute in ´ Zagreb, Croatia. Dr. Stepanic has participated in numerous research projects mainly in the fields of ´ medicinal chemistry and chemical biology. In her interdisciplinary collaborations, she focuses on the analysis of modes of action of compounds with mainly redox activities, using molecular modelling (DFT calculations, molecular docking, and dynamics) and big data analysis (pattern recognition, QSAR). She has been a member of several COST actions, scientific committees of several international scientific meetings, and international panels. She is a member of the Committee of the Medicinal and Pharmaceutical Chemistry Section of the Croatian Chemical Society, a member organization of the European Federation of Medicinal Chemistry and Chemical Biology (EFMC).

### **Marta Kuˇcerov´a-Chlup´aˇcov´a**

Dr. Marta Kucerov ˇ a, Ph.D. obtained her master's degree in Pharmacy as well as her Ph.D. in ´ Pharmaceutical Chemistry at Charles University, Faculty of Pharmacy in Hradec Kralov ´ e (Czech ´ Republic). She works as an assistant professor in the Department of Pharmaceutical Chemistry and Pharmaceutical Analysis of the Faculty of Pharmacy in Hradec Kralov ´ e. She was employed ´ in different research projects. She spent two research internships in the group of Prof. Dr. Michael Gutschow at the University of Bonn (Germany). In her research, she focuses on the synthesis of ¨ potential drugs, especially from the group of nitrogen-containing heterocycles, in silico drug design, and medicinal chemistry of antimicrobial and anticancer compounds.

She is a member of the State Examination Committee and the State Rigorosum Examination Committee for Pharmaceutical Chemistry at the faculty and a member of the committee of the Section of Synthetic Drugs in the Czech Pharmaceutical Society, which is an adhering organization of the European Federation for Medicinal chemistry and Chemical biology (EFMC). Marta Kucerov ˇ a holds ´ the function of the chair of the Editorial Committee of the Faculty of Pharmacy in Hradec Kralov ´ e´ and is a member of the Board for Equal Opportunities at Charles University (Czech Republic).
